Brand-Backed ASBM Pushes Back On Biosimilar Reforms

Association Questions FDA Findings On Switching And Interchangeability

 
• By David Wallace
  
Large yellow arrow opposing multiple small white arrows on chalkboard
The ASBM is pushing back against recent FDA moves on biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products